United States Antimony (NYSE:UAMY) EVP Lloyd Bardswich Buys 20,000 Shares of Stock

United States Antimony Co. (NYSE:UAMY) EVP Lloyd Bardswich acquired 20,000 shares of the company’s stock in a transaction dated Tuesday, September 1st. The stock was acquired at an average price of $4.63 per share, for a total transaction of $92,600.00. Following the completion of the purchase, the executive vice president directly owned 932,881 shares of the company’s stock, valued at $4,319,239.03. This trade represents a 2.19% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

United States Antimony Stock Performance

NYSE UAMY opened at $5.31 on Thursday. United States Antimony Co. has a twelve month low of $4.25 and a twelve month high of $19.71. The stock has a market capitalization of $794.45 million, a PE ratio of -40.83 and a beta of 0.39. The stock has a 50-day simple moving average of $5.90 and a 200 day simple moving average of $7.93.

Key United States Antimony News

Here are the key news stories impacting United States Antimony this week:

• Positive Sentiment: EVP Lloyd Bardswich purchased 20,000 shares for approximately $92,600, increasing his direct ownership by 2.19%. Insider buying can signal that management views the recent weakness as an attractive entry point. SEC filing
• Positive Sentiment: Director Joseph Carrabba bought 21,300 shares for $100,536, expanding his position by 12.03%. Combined with Bardswich’s purchase, insiders bought more than $193,000 of stock in the latest transactions. Insider buying report
• Positive Sentiment: A bullish analysis argues that second-quarter antimony volumes rose 26% year over year despite a 52% decline in realized prices. It also highlights a $245 million government contract that is beginning to convert into revenue, potentially providing a catalyst as deliveries accelerate. The analysis rates UAMY Buy with a $10–$11 target. Seeking Alpha analysis
• Neutral Sentiment: Market commentary described the advance as an isolated, company-specific bounce while other critical-minerals shares were weaker, suggesting UAMY’s move was driven more by insider purchases and its individual catalysts than by sector-wide strength. 247WallSt commentary
• Negative Sentiment: Risks remain significant: antimony pricing and trailing revenue are weak, and another analysis maintains a Sell view after reviewing expected shipments. The stock also remains well below its 52-week high, underscoring continued volatility. Seeking Alpha bearish analysis

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of United States Antimony in a research report on Wednesday, June 17th. HC Wainwright dropped their target price on shares of United States Antimony from $11.75 to $9.25 and set a “buy” rating on the stock in a research report on Wednesday, August 12th. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $10.12.

Institutional Investors Weigh In On United States Antimony

A number of institutional investors have recently added to or reduced their stakes in UAMY. BlackRock Inc. acquired a new position in United States Antimony in the 2nd quarter valued at approximately $82,365,000. State Street Corp grew its holdings in shares of United States Antimony by 30.5% during the 4th quarter. State Street Corp now owns 7,669,026 shares of the company’s stock worth $38,499,000 after purchasing an additional 1,794,234 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of United States Antimony by 22.5% during the 3rd quarter. Vanguard Group Inc. now owns 5,597,951 shares of the company’s stock worth $34,707,000 after purchasing an additional 1,026,412 shares in the last quarter. Geode Capital Management LLC increased its position in shares of United States Antimony by 22.3% during the fourth quarter. Geode Capital Management LLC now owns 2,655,922 shares of the company’s stock valued at $13,336,000 after purchasing an additional 484,172 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of United States Antimony by 448.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,344,780 shares of the company’s stock valued at $6,751,000 after purchasing an additional 1,099,634 shares during the period. 9.49% of the stock is owned by institutional investors and hedge funds.

About United States Antimony

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.